Precision BioSciences (DTIL) director receives grant of 20,979 RSUs

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Buehler Kevin reported acquisition or exercise transactions in this Form 4 filing.

PRECISION BIOSCIENCES INC director Kevin Buehler received a grant of 20,979 Restricted Stock Units (RSUs), each representing a contingent right to one share of common stock. These RSUs vest on the earlier of June 3, 2027, or the day immediately before the company’s next annual stockholder meeting, subject to his continued service. Following this compensation-related award, Buehler holds 20,979 RSUs directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Buehler Kevin

Role null

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	20,979	$0.00	--

Holdings After Transaction: Restricted Stock Units — 20,979 shares (Direct, null)

Footnotes (1)

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vest on the earlier to occur of (i) June 3, 2027 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

Key Figures

RSUs granted: 20,979 units RSU to share ratio: 1 RSU : 1 share Post-grant RSU holdings: 20,979 units +1 more

4 metrics

RSUs granted 20,979 units Restricted Stock Units granted to director on June 3, 2026

RSU to share ratio 1 RSU : 1 share Each RSU represents one share of common stock

Post-grant RSU holdings 20,979 units Total RSUs held by Kevin Buehler after the grant

Latest vesting date June 3, 2027 Latest possible vesting date for the RSUs, subject to service

Key Terms

Restricted Stock Units, contingent right, vest, annual meeting of stockholders

4 terms

Restricted Stock Units financial

"The security is described as Restricted Stock Units with underlying common stock."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"Each RSU represents a contingent right to receive one share of Common Stock."

vest financial

"The RSUs vest on the earlier of June 3, 2027, or before the next annual meeting."

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

annual meeting of stockholders financial

"Vesting may occur the day immediately prior to the next annual meeting of stockholders."

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

06/05/2026 - 07:35 AM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Buehler Kevin

(Last)

(First)

(Middle)

C/O PRECISION BIOSCIENCES, INC.

302 E. PETTIGREW ST, SUITE A-100

(Street)

DURHAM

NORTH CAROLINA

27701

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PRECISION BIOSCIENCES INC [ DTIL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽¹⁾	06/03/2026		A		20,979		⁽²⁾	⁽²⁾	Common Stock	20,979	$0	20,979	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

2. The RSUs vest on the earlier to occur of (i) June 3, 2027 and (ii) the day immediately prior to the Issuer's next annual meeting of stockholders following the grant date, in either case, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.

Remarks:

	/s/ Dario Scimeca, Attorney-in-Fact for Kevin Buehler	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did PRECISION BIOSCIENCES (DTIL) report for Kevin Buehler?

PRECISION BIOSCIENCES reported that director Kevin Buehler received 20,979 Restricted Stock Units. Each RSU is a contingent right to one share of common stock, representing a compensation-related equity award rather than an open-market stock purchase or sale.

How many Restricted Stock Units did Kevin Buehler receive from PRECISION BIOSCIENCES (DTIL)?

Kevin Buehler received 20,979 Restricted Stock Units from PRECISION BIOSCIENCES. These RSUs give him the right to receive an equal number of common shares if vesting conditions are met, aligning his compensation with the company’s share performance over time.

When do Kevin Buehler’s RSUs at PRECISION BIOSCIENCES (DTIL) vest?

The RSUs vest on the earlier of June 3, 2027, or the day immediately before the next annual stockholder meeting. Vesting also requires Kevin Buehler to continue serving the company through the applicable vesting date, tying the award to ongoing board service.

Is Kevin Buehler’s Form 4 transaction in DTIL an open-market trade?

No, the Form 4 transaction reflects a grant of 20,979 Restricted Stock Units as compensation. It is coded as a grant or award, not an open-market purchase or sale, so it does not represent a discretionary buy or sell of existing Precision BioSciences shares.

How many RSUs does Kevin Buehler hold in PRECISION BIOSCIENCES (DTIL) after this grant?

After the reported grant, Kevin Buehler holds 20,979 Restricted Stock Units. These RSUs are settled in common stock if the vesting conditions are satisfied, so they represent potential future ownership rather than currently issued and outstanding common shares.